Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular Events”

1,493 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,493 results

Not applicableStudy completedNCT03391128
What this trial is testing

Circulating P3NP and Cardiovascular Events in Hemodialysis Patients

Who this might be right for
Cardiovascular EventsCardiac Fibrosis
Toujinkai Hospital 244
Not applicableStudy completedNCT01198457
What this trial is testing

Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment

Who this might be right for
Breast NeoplasmsProstatic NeoplasmsMultiple Myeloma+1 more
Bayer 147
Not applicableUnknownNCT00456287
What this trial is testing

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome

Who this might be right for
Sleep ApneaCardiovascular Diseases
Sociedad Española de Neumología y Cirugía Torácica 40
Not applicableStudy completedNCT00753233
What this trial is testing

Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
National Heart, Lung, and Blood Institute (NHLBI) 145
Large-scale testing (Phase 3)Ended earlyNCT03521934
What this trial is testing

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
Lexicon Pharmaceuticals 1,222
Not applicableUnknownNCT03283306
What this trial is testing

Prognostic Value of Carotid CEUS in Acute Ischemic Stroke Patients

Who this might be right for
UltrasonographyCarotid StenosisIschemic Stroke
Seoul National University Hospital 667
Not applicableStudy completedNCT02514304
What this trial is testing

Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding

Who this might be right for
Gastrointestinal HemorrhageCardiovascular Diseases
Population Health Research Institute 4,745
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableStudy completedNCT02099565
What this trial is testing

Observational Prospective Study OPTIMA II - Follow-up

Who this might be right for
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
AstraZeneca 572
Not applicableUnknownNCT05221528
What this trial is testing

Association Between Lipid Profiles and Cardiovascular Events

Who this might be right for
DyslipidemiasCardiovascular Diseases
Seoul National University Hospital 4,234,339
Not applicableStudy completedNCT07165587
What this trial is testing

Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)

Who this might be right for
Pelvic FracturesAcetabular FracturesPelvic Trauma+4 more
Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu 81
Post-approval studies (Phase 4)UnknownNCT03882775
What this trial is testing

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

Who this might be right for
STEMIPercutaneous Coronary InterventionAged
The First Affiliated Hospital of Dalian Medical University 240
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242599
What this trial is testing

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Who this might be right for
Ischemic Cerebral Infarction
Beijing Tiantan Hospital 4,810
Not applicableUnknownNCT04976764
What this trial is testing

The Correlation Between Cirrhotic Cardiomyopathy and Perioperative Cardiovascular Events in Liver Transplantation

Who this might be right for
Cirrhosis, Liver
The Affiliated Hospital of Qingdao University 850
Post-approval studies (Phase 4)Looking for participantsNCT06909565
What this trial is testing

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Who this might be right for
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University 6,000
Not applicableUnknownNCT05562089
What this trial is testing

Prevail Drug Balloon Study

Who this might be right for
Myocardial InfarctionDrug-Coated Balloon
Chinese University of Hong Kong 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06077864
What this trial is testing

Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Who this might be right for
Obesity
Boehringer Ingelheim 5,533
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Load More Results